Drug intelligence / Profile preview

Zhushui Decoction

Development stage: Unknown
Lead developer: Shanghai Municipal Hospital of Traditional Chinese Medicine
Administration: Oral, Topical

Overview

Zhushui Decoction is a Traditional Chinese Medicine (TCM) herbal formula developed by the Shanghai Hospital of Traditional Chinese Medicine for the treatment of breast cancer-related lymphedema (BCRL). It is administered through a combination of oral intake and external application (topical) to reduce upper limb edema in patients who have undergone breast cancer surgery. The formula is designed to address the TCM pathological states of dampness and blood stasis, facilitating the drainage of excess fluid and improving lymphatic circulation.

Other names: ZhuShui Decoction

Beyond the preview

Go deeper on Zhushui Decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhushui Decoction.

Explore the full profile